Fisher & Paykel Healthcare logo

FPH - Fisher & Paykel Healthcare Share Price

NZD33.39 1.2  3.8%

Last Trade - 5:59am

Large Cap
Market Cap £9.50bn
Enterprise Value £9.48bn
Revenue £822.0m
Position in Universe 29th / 1896
Unlock FPH Revenue
Relative Strength (%)
1m +7.25%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -15.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
672.3 815.5 894.4 980.8 1,070 1,264 2,067 1,725 +13.5%
+14.2 +26.2 +27.6 -1.9 +24.6 +26.9 +95.9 -26.4
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 September 2020, Fisher &Paykel Healthcare Corp Ltd revenues increased 59% toNZ$910.2M. Net income increased 86% to NZ$225.5M. Revenuesreflect North America segment increase of 44% to NZ$373.9M,Europe segment increase of 70% to NZ$269.9M. Net incomebenefited from Exchange gain/(loss) on foreign currencyincrease from NZ$5.7M (expense) to NZ$5.3M (income).Dividend per share increased from NZ$0.12 to NZ$0.16.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for FPH
Graphical History


FPH Revenue Unlock FPH Revenue

Net Income

FPH Net Income Unlock FPH Revenue

Normalised EPS

FPH Normalised EPS Unlock FPH Revenue

PE Ratio Range

FPH PE Ratio Range Unlock FPH Revenue

Dividend Yield Range

FPH Dividend Yield Range Unlock FPH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
FPH EPS Forecasts Unlock FPH Revenue
Profile Summary

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.

Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated July 27, 1954
Public Since November 13, 2001
No. of Shareholders: 24,551
No. of Employees: 5,081
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Developed Asia Pacific , FTSE Developed Asia Pacific Ex Japan ,
Exchange New Zealand Stock Exchange
Shares in Issue 576,123,608
Free Float (0.0%)
Eligible for
FPH Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for FPH
Upcoming Events for FPH
Sunday 23rd May, 2021 Estimate
Full Year 2021 Fisher & Paykel Healthcare Corporation Ltd Earnings Release
Sunday 23rd May, 2021 Estimate
Full Year 2021 Fisher & Paykel Healthcare Corporation Ltd Earnings Release
Frequently Asked Questions for Fisher & Paykel Healthcare
What is the Fisher & Paykel Healthcare share price?

As of 5:59am, shares in Fisher & Paykel Healthcare are trading at NZD33.39, giving the company a market capitalisation of £9.50bn. This share price information is delayed by 15 minutes.

How has the Fisher & Paykel Healthcare share price performed this year?

Shares in Fisher & Paykel Healthcare are currently trading at NZD33.39 and the price has moved by 19.15% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Fisher & Paykel Healthcare price has moved by -8.6% over the past year.

What are the analyst and broker recommendations for Fisher & Paykel Healthcare?

Of the analysts with advisory recommendations for Fisher & Paykel Healthcare, there are there are currently 1 "buy" , 1 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Fisher & Paykel Healthcare is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Fisher & Paykel Healthcare next release its financial results?

Fisher & Paykel Healthcare is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Fisher & Paykel Healthcare dividend yield?

The Fisher & Paykel Healthcare dividend yield is 0.98% based on the trailing twelve month period.

Does Fisher & Paykel Healthcare pay a dividend?

Last year, Fisher & Paykel Healthcare paid a total dividend of 0.32, and it currently has a trailing dividend yield of 0.98%. Looking ahead, Fisher & Paykel Healthcare has not announced an ex-dividend date yet.

When does Fisher & Paykel Healthcare next pay dividends?

Fisher & Paykel Healthcare has yet to annouce their ex-dividend date. The historic dividend yield on Fisher & Paykel Healthcare shares is currently 0.98%.

How do I buy Fisher & Paykel Healthcare shares?

To buy shares in Fisher & Paykel Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Fisher & Paykel Healthcare?

Shares in Fisher & Paykel Healthcare are currently trading at NZD33.39, giving the company a market capitalisation of £9.50bn.

Where are Fisher & Paykel Healthcare shares listed? Where are Fisher & Paykel Healthcare shares listed?

Here are the trading details for Fisher & Paykel Healthcare:

Country of listing: New Zealand
Exchange: NZC
Ticker Symbol: FPH
What kind of share is Fisher & Paykel Healthcare?

Based on an overall assessment of its quality, value and momentum, Fisher & Paykel Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Fisher & Paykel Healthcare share price forecast 2021?

Shares in Fisher & Paykel Healthcare are currently priced at NZD33.39. At that level they are trading at 1.81% discount to the analyst consensus target price of 0.00.

Analysts covering Fisher & Paykel Healthcare currently have a consensus Earnings Per Share (EPS) forecast of 0.972 for the next financial year.

How can I tell whether the Fisher & Paykel Healthcare share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fisher & Paykel Healthcare. Over the past six months, the relative strength of its shares against the market has been -20.45%. At the current price of NZD33.39, shares in Fisher & Paykel Healthcare are trading at -4.27% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Fisher & Paykel Healthcare PE Ratio?

The Fisher & Paykel Healthcare PE ratio based on its reported earnings over the past 12 months is 47.6. The shares are currently trading at NZD33.39.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare's management team is headed by:

Michael Daniell - NED
Lewis Gradon - CEO
Paul Shearer - SVP
Antony Carter - NEC
Geraldine McBride - NID
Winston Fong - VPR
Andrew Robert Somervell - VPR
Brian Schultz - VPR
Jonti Rhodes - GMG
Philippa Mary Greenwood - NID
Debra Lumsden - VPR
Nicholas Fourie - VPR
Lyndal York - CFO
Neville Mitchell - NID
Marcus Driller - VPR
Who are the major shareholders of Fisher & Paykel Healthcare?

Here are the top five shareholders of Fisher & Paykel Healthcare based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 5.23% (30.1m shares)
Capital Research Global Investors Investment Advisor
Percentage owned: 4.79% (27.6m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 3.26% (18.8m shares)
Accident Compensation Corporation Insurance Company
Percentage owned: 2.11% (12.2m shares)
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund
Percentage owned: 1.57% (9.07m shares)
Similar to FPH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.